176 related articles for article (PubMed ID: 23400510)
21. Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer.
Masi G; Cupini S; Marcucci L; Cerri E; Loupakis F; Allegrini G; Brunetti IM; Pfanner E; Viti M; Goletti O; Filipponi F; Falcone A
Ann Surg Oncol; 2006 Jan; 13(1):58-65. PubMed ID: 16372158
[TBL] [Abstract][Full Text] [Related]
22. Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy.
Nuzzo G; Giuliante F; Ardito F; Vellone M; Pozzo C; Cassano A; Giovannini I; Barone C
J Gastrointest Surg; 2007 Mar; 11(3):318-24. PubMed ID: 17458605
[TBL] [Abstract][Full Text] [Related]
23. Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study).
Hatano E; Okuno M; Nakamura K; Ishii T; Seo S; Taura K; Yasuchika K; Yazawa T; Zaima M; Kanazawa A; Terajima H; Kaihara S; Adachi Y; Inoue N; Furumoto K; Manaka D; Tokka A; Furuyama H; Doi K; Hirose T; Horimatsu T; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):634-45. PubMed ID: 25926024
[TBL] [Abstract][Full Text] [Related]
24. The Management of Recurrence within Six Months after Hepatic Resection for Colorectal Liver Metastasis.
Inoue Y; Fujii K; Kagota S; Tomioka A; Yamaguchi T; Ohama H; Hamamoto H; Ishii M; Osumi W; Tsuchimoto Y; Terazawa T; Ogura T; Masubuchi S; Yamamoto M; Imoto A; Asai A; Komeda K; Fukunishi S; Hirokawa F; Goto M; Tanaka K; Okuda J; Higuchi K; Uchiyama K
Dig Surg; 2020; 37(4):282-291. PubMed ID: 31597148
[TBL] [Abstract][Full Text] [Related]
25. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
[TBL] [Abstract][Full Text] [Related]
26. Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases.
Dexiang Z; Li R; Ye W; Haifu W; Yunshi Z; Qinghai Y; Shenyong Z; Bo X; Li L; Xiangou P; Haohao L; Lechi Y; Tianshu L; Jia F; Xinyu Q; Jianmin X
Ann Surg Oncol; 2012 Sep; 19(9):2860-8. PubMed ID: 22526903
[TBL] [Abstract][Full Text] [Related]
27. A randomized phase II trial of three intensified chemotherapy regimens in first-line treatment of colorectal cancer patients with initially unresectable or not optimally resectable liver metastases. The METHEP trial.
Ychou M; Rivoire M; Thezenas S; Quenet F; Delpero JR; Rebischung C; Letoublon C; Guimbaud R; Francois E; Ducreux M; Desseigne F; Fabre JM; Assenat E
Ann Surg Oncol; 2013 Dec; 20(13):4289-97. PubMed ID: 23955585
[TBL] [Abstract][Full Text] [Related]
28. Detailed pathologic characteristics of the primary colorectal tumor independently predict outcome after hepatectomy for metastases.
Cardona K; Mastrodomenico P; D'Amico F; Shia J; Gönen M; Weiser MR; Paty PB; Kingham TP; Allen PJ; De Matteo RP; Fong Y; Jarnagin WR; D'Angelica MI
Ann Surg Oncol; 2013 Jan; 20(1):148-54. PubMed ID: 22847127
[TBL] [Abstract][Full Text] [Related]
29. Metastatic tumor doubling time: most important prehepatectomy predictor of survival and nonrecurrence of hepatic colorectal cancer metastasis.
Tanaka K; Shimada H; Miura M; Fujii Y; Yamaguchi S; Endo I; Sekido H; Togo S; Ike H
World J Surg; 2004 Mar; 28(3):263-70. PubMed ID: 14961200
[TBL] [Abstract][Full Text] [Related]
30. Indications for conversion hepatectomy for initially unresectable colorectal cancer with liver metastasis.
Sugiyama M; Uehara H; Shin Y; Shiokawa K; Fujimoto Y; Mano Y; Komoda M; Nakashima Y; Sugimachi K; Yamamoto M; Morita M; Toh Y
Surg Today; 2022 Apr; 52(4):633-642. PubMed ID: 34762175
[TBL] [Abstract][Full Text] [Related]
31. Risk Factors for Unresectable Recurrence After Up-Front Surgery for Colorectal Liver Metastasis.
Hokuto D; Nomi T; Yasuda S; Yoshikawa T; Ishioka K; Yamada T; Akahori T; Nakagawa K; Nagai M; Nakamura K; Obara S; Kanehiro H; Sho M
World J Surg; 2018 Mar; 42(3):884-891. PubMed ID: 28879511
[TBL] [Abstract][Full Text] [Related]
32. Liver resection after chemotherapy and tumour downsizing in patients with initially unresectable colorectal cancer liver metastases.
Devaud N; Kanji ZS; Dhani N; Grant RC; Shoushtari H; Serrano PE; Nanji S; Greig PD; McGilvray I; Moulton CA; Wei A; Gallinger S; Cleary SP
HPB (Oxford); 2014 May; 16(5):475-80. PubMed ID: 23927606
[TBL] [Abstract][Full Text] [Related]
33. Long-term results of hepatectomy after hepatic arterial infusion chemotherapy for initially unresectable hepatic colorectal metastases.
Fujimoto Y; Akasu T; Yamamoto S; Fujita S; Moriya Y
J Gastrointest Surg; 2009 Sep; 13(9):1643-50. PubMed ID: 19582514
[TBL] [Abstract][Full Text] [Related]
34. A pilot study of multimodality therapy for initially unresectable liver metastases from colorectal carcinoma: hepatic resection after hepatic arterial infusion chemotherapy and portal embolization.
Akasu T; Moriya Y; Takayama T
Jpn J Clin Oncol; 1997 Oct; 27(5):331-5. PubMed ID: 9390211
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of conversion chemotherapy for initially unresectable synchronous colorectal liver metastasis.
Baba K; Oshita A; Kohyama M; Inoue S; Kuroo Y; Yamaguchi T; Nakamura H; Sugiyama Y; Tazaki T; Sasaki M; Imamura Y; Daimaru Y; Ohdan H; Nakamitsu A
World J Gastroenterol; 2015 Feb; 21(6):1982-8. PubMed ID: 25684967
[TBL] [Abstract][Full Text] [Related]
36. Does "conversion chemotherapy" really improve survival in metastatic colorectal cancer patients with liver-limited disease?
Kataoka K; Kanazawa A; Iwamoto S; Kato T; Nakajima A; Arimoto A
World J Surg; 2014 Apr; 38(4):936-46. PubMed ID: 24166026
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
[TBL] [Abstract][Full Text] [Related]
38. Short time to recurrence after hepatic resection correlates with poor prognosis in colorectal hepatic metastasis.
Takahashi S; Konishi M; Nakagohri T; Gotohda N; Saito N; Kinoshita T
Jpn J Clin Oncol; 2006 Jun; 36(6):368-75. PubMed ID: 16762969
[TBL] [Abstract][Full Text] [Related]
39. Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?
Reddy SK; Tsung A; Marsh JW; Geller DA
J Surg Oncol; 2012 Jan; 105(1):55-9. PubMed ID: 21842519
[TBL] [Abstract][Full Text] [Related]
40. Comparison between perioperative and postoperative chemotherapy after potentially curative hepatic resection for metastatic colorectal cancer.
Araujo R; Gonen M; Allen P; Blumgart L; DeMatteo R; Fong Y; Kemeny N; Jarnagin W; D'Angelica M
Ann Surg Oncol; 2013 Dec; 20(13):4312-21. PubMed ID: 23897009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
